Virax Biolabs (VRAX) announced that it received a notice from Nasdaq, notifying the company that it is not in compliance with the minimum bid for continued listing on the Nasdaq.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRAX: